Is triple-negative breast cancer more likely to metastasize?
In particular, women with triple-negative breast cancer were four times more likely to experience a visceral metastasis within five years of diagnosis than those with other types of cancer (HR 4.0; 95% CI: 2.7-5.9; P < 0.0001).
Where does triple-negative breast cancer usually recur?
Studies have shown that triple-negative breast cancer is more likely to spread beyond the breast and more likely to recur (come back) after treatment. It tends to be higher grade than other types of breast cancer.
How long can you live with triple-negative?
5-year relative survival rates for triple-negative breast cancer
| SEER Stage | 5-year Relative Survival Rate |
|---|---|
| Localized | 91% |
| Regional | 65% |
| Distant | 12% |
| All stages combined | 77% |
How long can you live with metastatic triple-negative breast cancer?
Median survival with MBC was 13.3 months (range, 0.8-99.8 months). Median duration of first-line palliative therapy was 11.9 weeks (range, 0-73.1 weeks).
What are the odds of surviving triple negative breast cancer?
The subtype triple negative (ER- PR- HER2-) breast cancer had the worst survival rates over all three stages. At stage I the 5-year survival rate was 92.9% and at stage III 48.9%.
What are the stages of triple negative breast cancer?
Stage 0 – Abnormal cells are confined to the milk ducts or lobes
What is the prognosis for triple negative breast cancer?
While prognosis is, on average, poorer than with hormone receptor or human epidermal growth factor receptor 2 (HER2) positive tumors, triple-negative breast cancer is a very diverse disease. On a positive note, and unlike hormone-positive tumors that commonly recur late (after five years), late recurrence is less common with triple-negative tumors.
What is the survival rate for triple negative breast cancer?
The five-year survival rate for someone with localized triple-negative breast cancer, cancer that has not spread beyond the breast, is 91 percent (91 percent as likely as someone without cancer to survive during the five-year period). For cancer that has spread into nearby lymph nodes or nearby areas, the five-year survival rate is 65 percent.